Suppr超能文献

新冠疫情后儿科急诊科呼吸道病毒检测的趋势

Trends in Respiratory Viral Testing in Pediatric Emergency Departments Following the COVID-19 Pandemic.

作者信息

Ramgopal Sriram, Badaki-Makun Oluwakemi, Eltorki Mohamed, Chaudhari Pradip, Phamduy Timothy T, Shapiro Daniel, Rees Chris A, Bergmann Kelly R, Neuman Mark I, Lorenz Douglas, Michelson Kenneth A

机构信息

Division of Emergency Medicine, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.

Division of Pediatric Emergency Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

Ann Emerg Med. 2025 Feb;85(2):111-121. doi: 10.1016/j.annemergmed.2024.08.508. Epub 2024 Oct 16.

Abstract

STUDY OBJECTIVE

To evaluate for increases in the use and costs of respiratory viral testing in pediatric emergency departments (EDs) because of the COVID-19 pandemic.

METHODS

We performed a cross-sectional study using the pediatric health information system. Eligible subjects were children (90 days to 18 years) who were discharged from a pediatric ED and included in the pediatric health information system from October 2016 through March 2024. To evaluate for changes in the frequency and costs of respiratory viral testing, we performed an interrupted time series analysis across 3 study periods: prepandemic (October 1, 2016 to March 14, 2020), early pandemic (March 15, 2020 to December 31, 2023), and late pandemic (January 1, 2023 to March 31, 2024).

RESULTS

We included 15,261,939 encounters from 34 pediatric EDs over the 90-month study period. At least 1 viral respiratory test was performed for 460,826 of 7,311,177 prepandemic encounters (6.3%), 1,240,807 of 5,100,796 early pandemic encounters (24.3%), and 545,696 of 2,849,966 late pandemic encounters (19.1%). There was a positive prepandemic slope in viral testing (0.17% encounters/month; 95% CI 0.17 to 0.18). The early pandemic was associated with a shift change of 4.98% (95% CI 4.90 to 5.07) and a positive slope (0.54% encounters/month; 95% CI 0.54 to 0.55). The late pandemic period was associated with a negative shift (-17.80%; 95% CI -17.90 to -17.70) and a positive slope (0.42% encounters/month; 95% CI 0.41 to 0.42). The slope in testing costs increased from $5,000/month (95% CI $4,200 to $5,700) to $33,000/month (95% CI $32,000 to $34,000) during the early pandemic.

CONCLUSION

Respiratory testing and associated costs increased during the COVID-19 pandemic and were sustained despite decreasing incidence of disease. These findings highlight a need for further efforts to clarify indications for viral testing in the ED and efforts to reduce low-value testing.

摘要

研究目的

评估由于新冠疫情,儿科急诊科呼吸道病毒检测的使用情况和成本增加情况。

方法

我们使用儿科健康信息系统进行了一项横断面研究。符合条件的受试者为2016年10月至2024年3月期间从儿科急诊科出院并纳入儿科健康信息系统的儿童(90天至18岁)。为了评估呼吸道病毒检测频率和成本的变化,我们在三个研究期间进行了中断时间序列分析:疫情前(2016年10月1日至2020年3月14日)、疫情早期(2020年3月15日至2023年12月31日)和疫情后期(2023年1月1日至2024年3月31日)。

结果

在90个月的研究期间,我们纳入了来自34个儿科急诊科的15,261,939次就诊病例。在疫情前的7,311,177次就诊病例中,有460,826次(6.3%)至少进行了1次病毒呼吸道检测;在疫情早期的5,100,796次就诊病例中,有1,240,807次(24.3%);在疫情后期的2,849,966次就诊病例中,有545,696次(19.1%)。疫情前病毒检测呈正斜率(每月就诊病例的0.17%;95%置信区间为0.17至0.18)。疫情早期与4.98%的变化(95%置信区间为4.90至5.07)和正斜率(每月就诊病例的0.54%;95%置信区间为0.54至0.55)相关。疫情后期与负变化(-17.80%;95%置信区间为-17.90至-17.70)和正斜率(每月就诊病例的0.42%;95%置信区间为0.41至0.42)相关。在疫情早期,检测成本的斜率从每月5000美元(95%置信区间为4200美元至5700美元)增加到每月33000美元(95%置信区间为32000美元至34000美元)。

结论

在新冠疫情期间,呼吸道检测及相关成本增加,尽管疾病发病率下降,但仍持续存在。这些发现凸显了进一步努力明确急诊科病毒检测指征以及减少低价值检测的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验